Literature DB >> 25364514

Quantifying the expression of tumor marker genes in lung squamous cell cancer with RNA sequencing.

Lin Wang1, Cheng Zhan1, Yongxing Zhang1, Jun Ma1, Junjie Xi1, Wei Jiang1, Yu Shi1, Qun Wang1.   

Abstract

BACKGROUND: We measured the expression of some commonly used tumor markers with RNA sequencing (RNA-Seq) to identify any that might be useful for the evaluation of squamous cell lung cancer and identify possible correlations between these tumor markers and any clinical characteristics.
METHODS: RNA-Seq was performed on five pairs of squamous-cell lung cancer and normal tissues and another 39 squamous-cell lung cancer tissues obtained by our department between September and December, 2012. The expression of 13 commonly used tumor markers was determined.
RESULTS: All of the patients in our study were male. The expressions of CA125, CYFRA21-1, NSE and SCC increased in tumor samples and there were statistically significant differences between squamous cell lung cancer and normal tissues (P=0.008, P<0.001, P<0.001, P=0.001). The expression of β2M and CA15-3 was reduced in squamous cell carcinoma relative to normal tissues and there was no significant difference in the expression of other tumor markers, including AFP, AFU, CT, FER and HE4.
CONCLUSIONS: CA125, CYFRA21-1, NSE and SCC may be appropriate tumor markers for squamous cell lung cancer.

Entities:  

Keywords:  RNA sequencing (RNA-Seq); squamous cell lung cancer; tumor marker

Year:  2014        PMID: 25364514      PMCID: PMC4215159          DOI: 10.3978/j.issn.2072-1439.2014.08.27

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  33 in total

Review 1.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 2.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

3.  Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells.

Authors:  Y Uemura; S C Pak; C Luke; S Cataltepe; C Tsu; C Schick; Y Kamachi; S L Pomeroy; D H Perlmutter; G A Silverman
Journal:  Int J Cancer       Date:  2000-07-20       Impact factor: 7.396

4.  Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Authors:  Mary T Galgano; Garret M Hampton; Henry F Frierson
Journal:  Mod Pathol       Date:  2006-06       Impact factor: 7.842

5.  Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.

Authors:  N Mino; A Iio; K Hamamoto
Journal:  Cancer       Date:  1988-08-15       Impact factor: 6.860

6.  Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera.

Authors:  M Dietel; H Arps; R Klapdor; S Müller-Hagen; M Sieck; L Hoffmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).

Authors:  Domenico Ferrigno; Gianfranco Buccheri; Cristina Giordano
Journal:  Lung Cancer       Date:  2003-09       Impact factor: 5.705

Review 8.  Biological role of SCC antigen.

Authors:  Y Suminami; S Nawata; H Kato
Journal:  Tumour Biol       Date:  1998

9.  Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer.

Authors:  M Hammad Ather; Farhat Abbas; Nuzhat Faruqui; Mohammad Israr; Shahid Pervez
Journal:  BMC Urol       Date:  2008-12-30       Impact factor: 2.264

10.  Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer.

Authors:  M Diez; A Gomez; F Hernando; M D Ortega; M L Maestro; A Torres; J M Mugüerza; A Gutierrez; J Granell; J L Balibrea
Journal:  Int J Biol Markers       Date:  1995 Jan-Mar       Impact factor: 3.248

View more
  2 in total

1.  Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer.

Authors:  Nabil Abdalla; Robert Piorkowski; Anna Slomka; Malgorzata Kania; Wlodzimierz Sawicki; Krzysztof Cendrowski
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12

2.  Integrated TCGA analysis implicates lncRNA CTB-193M12.5 as a prognostic factor in lung adenocarcinoma.

Authors:  Xuehai Wang; Gang Li; Qingsong Luo; Jiayong Xie; Chongzhi Gan
Journal:  Cancer Cell Int       Date:  2018-02-22       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.